EP Patent

EP0193355A2 — Analgesic composition

Assigned to Eli Lilly and Co · Expires 1986-09-03 · 40y expired

What this patent protects

Codeine in combination with fluoxetine or norfluoxetine, optionally in further combination with aspirin or acetominophen, is a synergistic analgesic composition.

USPTO Abstract

Codeine in combination with fluoxetine or norfluoxetine, optionally in further combination with aspirin or acetominophen, is a synergistic analgesic composition.

Drugs covered by this patent

chembl-chembl2103744 (MORPHINE SULFATE)

Patent Metadata

Patent number: EP0193355A2
Jurisdiction: EP
Classification: —
Expires: 1986-09-03
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.